Hostname: page-component-7479d7b7d-c9gpj Total loading time: 0 Render date: 2024-07-11T23:29:19.038Z Has data issue: false hasContentIssue false

Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan

Published online by Cambridge University Press:  25 April 2002

T. ENDOH
Affiliation:
Division of Laboratory Diagnosis, Sapporo Medical University School of Medicine, Sapporo, Japan
A. YAGIHASHI
Affiliation:
Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
N. UEHARA
Affiliation:
Division of Laboratory Diagnosis, Sapporo Medical University School of Medicine, Sapporo, Japan
D. KOBAYASHI
Affiliation:
Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
N. TSUJI
Affiliation:
Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
M. NAKAMURA
Affiliation:
Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
S. HAYASHI
Affiliation:
Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo, Japan
N. FUJII
Affiliation:
Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo, Japan
N. WATANABE
Affiliation:
Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Thirty Japanese clinical isolates of Mycobacterium tuberculosis were analysed by pyrazinamide susceptibility testing and pyrazinamidase assay, as well as polymerase chain reaction for single-strand conformational polymorphism and direct sequencing of the gene encoding pyrazinamidase (pncA). All sensitive isolates showed pyrazinamidase activity and a wild-type pncA gene, but three resistant isolates had pncA gene mutations and lacked pyrazinamidase activity. The latter isolates showed a minimum inhibitory concentration of at least 100 mg/l by the 7H10 agar proportion method and 400 mg/l by the 7H9 liquid medium method. Isolate 28 showed T-to-C change at position 11, leading to Leu4→Ser substitution; isolate 29 had an 8-bp deletion from position 382; and isolate 30 had A-to-C change at position 29, leading to Gln10→Pro substitution. The deletion has not been described previously. This is the first demonstration of pncA gene mutations in PZA-resistant M. tuberculosis strains isolated from Japanese patients.

Type
Short Report
Copyright
© 2002 Cambridge University Press